Targeted Medical Pharma announced preliminary data indicating its new product, Percura capsules, reduced symptoms of pain and numbness related to peripheral neuropathy. Percura is a new amino-acid based prescription medical food designed for the dietary management of the metabolic processes associated with pain, inflammation, and loss of sensation due to peripheral neuropathy.
Preliminary studies demonstrated Percura reduced numbness in 57% of patients and pain in 56% of patients after 30 days of treatment. The 60-day study will be completed by the end of 2012.
Percura is a prescription medical food that acts by providing the nutritional requirements that support the synthesis and physiological activities of neurotransmitters involved in neuropathic pain.
For more information call (310) 531-7089 or visit www.tmedpharma.com.